Vitak, Maastricht University
Innovative Medical Devices
Innovation & Research
MGP Center
Human Trial Center: ICHIS
Education
Measurements & Resources

History

1988:  The Cardiovascular Research Institute Maastricht (CARIM) was founded.

 

2001:  Professor Dr. Cees Vermeer founded Vitak Innovation in Life Science. 

 

2006:  Our expertise and infrastructure for executing human intervention trials was made available for third parties in the food-, pharmaceutical-, and medical devices industry. 

 

2010:  Vitak Innovation in Life Science reported a conformation-specific Assay for Vascular Matrix Gla-Protein (MGP) which is predictive for cardiovascular mortality both in various patient groups and in the healthy population.

 

2010:  Vitak Innovation in Life Science focused on the development of Point of Care and In Vitro Diagnostics.

 

2012:  Our specialized diagnostic facilities were expanded with a Routine Diagnostics Service in which both newly developed biomarkers and commercially available markers are routinely tested for third parties (mainly academic groups as well as the food-, pharmaceutical-, and medical devices industry).

 

2014:  Opening of our office in the United Arab Emirates. This office is our point of support and center of activities in the Middle East. 

 

2016:  Introduction of Vita K Meter (Point of Care)

 

2016:  Introduction of prototype TransCare (In Vitro Diagnostics)